Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Inventory Average: 2014-2025

Historic Inventory Average for Amphastar Pharmaceuticals (AMPH) over the last 11 years, with Sep 2025 value amounting to $188.8 million.

  • Amphastar Pharmaceuticals' Inventory Average rose 49.44% to $188.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $188.8 million, marking a year-over-year increase of 49.44%. This contributed to the annual value of $129.8 million for FY2024, which is 23.95% up from last year.
  • According to the latest figures from Q3 2025, Amphastar Pharmaceuticals' Inventory Average is $188.8 million, which was up 0.12% from $188.6 million recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Inventory Average ranged from a high of $188.8 million in Q3 2025 and a low of $94.0 million during Q1 2022.
  • For the 3-year period, Amphastar Pharmaceuticals' Inventory Average averaged around $133.5 million, with its median value being $119.0 million (2024).
  • Its Inventory Average has fluctuated over the past 5 years, first declined by 11.20% in 2021, then skyrocketed by 58.55% in 2025.
  • Amphastar Pharmaceuticals' Inventory Average (Quarterly) stood at $96.5 million in 2021, then increased by 7.14% to $103.4 million in 2022, then rose by 4.34% to $107.9 million in 2023, then surged by 31.62% to $142.0 million in 2024, then skyrocketed by 49.44% to $188.8 million in 2025.
  • Its last three reported values are $188.8 million in Q3 2025, $188.6 million for Q2 2025, and $169.6 million during Q1 2025.